Avacopan: First Approval

2021/11/26 by Arnold Lee · 26 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Vasculitis and related conditions #Urticaria and Related Conditions #Inflammasome and immune disorders

paper · doi:10.1007/s40265-021-01643-6

Citations

• 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

Cited by

• Functional dynamics of G protein-coupled receptors reveal new routes for drug discovery
• New and Emerging Targeted Therapies for Hidradenitis Suppurativa. [europepmc]
• The C5a/C5aR1 Axis Contributes to the Pathogenesis of Acute Cystitis Through Enhancement of Adhesion and Colonization of Uropathogenic E. coli . [europepmc]
• A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2021. [europepmc]
• Mannan-Binding Lectin Promotes Murine Graft-versus-Host Disease by Amplifying Lipopolysaccharide-Initiated Inflammation. [europepmc]
• Complement Inhibition in ANCA-Associated Vasculitis. [europepmc]
• Anaphylatoxins spark the flame in early autoimmunity. [europepmc]
• The Latest FDA-Approved Pharmaceuticals Containing Fragments of Tailor-Made Amino Acids and Fluorine. [europepmc]
• Gene targeting as a therapeutic avenue in diseases mediated by the complement alternative pathway. [europepmc]
• Mechanism of activation and biased signaling in complement receptor C5aR1. [europepmc]
• Allosteric modulation of G protein-coupled receptor signaling. [europepmc]
• Structure, function and drug discovery of GPCR signaling. [europepmc]
• Novel and potential future therapeutic options in systemic autoimmune diseases. [europepmc]
• G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery. [europepmc]
• Hidradenitis Suppurativa: A Review of the Biologic and Small Molecule Immunomodulatory Treatments. [europepmc]
• Neutrophil diversity and function in health and disease. [europepmc]
• Toxin protein LukS-PV targeting complement receptor C5aR1 inhibits cell proliferation in hepatocellular carcinoma via the HDAC7-Wnt/β-catenin axis. [europepmc]
• Functional dynamics of G protein-coupled receptors reveal new routes for drug discovery. [europepmc]
• The association between serum lipids at diagnosis and renal outcome in microscopic polyangiitis patients. [europepmc]
• Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics. [europepmc]
• Post-marketing safety profile and clinical prioritization of adverse events with avacopan in ANCA-associated vasculitis: a FAERS pharmacovigilance analysis. [europepmc]
• The safety profiles of avacopan on microscopic polyangiitis and granulomatosis with polyangiitis: a real-world pharmacovigilance analysis. [europepmc]
• Harnessing T-cell therapy for lupus nephritis: Opportunities and challenges. [europepmc]
• A Real-World Disproportionality Analysis of Avacopan in Anti-Neutrophil Cytoplasmic Antibodies Associated Vasculitis: Insights From FDA Adverse Event Reporting System. [europepmc]
• The complement cascade in Alzheimer's disease: modern implications of an ancient immune protagonist. [europepmc]
• The Complement System in ANCA-Associated Vasculitis: Mechanistic Insights, Therapeutic Horizons, and Unmet Clinical Needs. [europepmc]